Latest Advertising News

Aspermont reports its 34th consecutive quarter of subscription growth, with Annual Recurring Revenue rising to $11.4 million and promising new revenue streams emerging in advertising and live events.

News Corporation reported a robust second quarter for Fiscal 2025, with revenues climbing 5% to $2.24 billion and net income soaring 58%, while announcing the strategic sale of Foxtel to DAZN for A$3.4 billion.

REA Group Ltd has delivered a robust half-year performance, reporting a 20% increase in revenue to $872.9 million and a 26% rise in net profit after tax to $313.9 million, driven by strong growth in both Australian and Indian markets.

REA Group announces CEO Owen Wilson will retire in the second half of 2025, concluding a decade marked by strong growth and innovation. The board has commenced a search for his successor to ensure a seamless leadership transition.

Rewardle Holdings Limited reported a robust net cash inflow from operating activities of $3.98 million for Q4 2024, offsetting significant investing outflows and ending the quarter with $1.23 million in cash.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Atomos Limited reported a 7% increase in Q2 FY25 sales driven by its core Shinobi II product, but faced margin pressures due to discounting and competitive pricing. The company is finalizing a cost restructure and reviewing funding options to support future growth.

Carly Holdings Limited has reported a 41% jump in customer receipts and its highest-ever subscription revenue in the December 2024 quarter, alongside significant cost reductions and strategic fleet adjustments.

Nutritional Growth Solutions reported a slight revenue decline in Q4 FY24 but remains optimistic about growth and profitability in FY25, buoyed by renewed Walmart partnerships and expanding Asian distribution.

RooLife Group (ASX: RLG) reported a striking 144% increase in sales revenue for Q2 FY2025, driven by the launch of new online stores across China, Hong Kong, Australia, and India. The company is investing heavily in product development and marketing to capitalize on booming health and wellness markets.

Wellnex Life Limited reported a 36% rise in Q2 FY25 cash receipts and record monthly sales, while advancing its dual listing on the London Stock Exchange and expanding into the UK market.

Anagenics Limited reports a marked reduction in cash outflows and operating costs following a strategic restructuring, with full benefits expected in the latter half of FY2025. Despite divesting Face Medi, core cosmetics sales remain steady.